Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » PCR » Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China

Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China

Dec 23, 2020
|
staff reporter

NEW YORK – Amoy Diagnostics announced Wednesday that it has signed an agreement with Merck KGaA to develop a companion diagnostic test in China to support Merck KGaA's novel MET inhibitor tepotinib (Tepmetko).

Tepotinib is a selective small molecule drug designed to inhibit MET in subjects with non-small cell lung cancer and MET alterations. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Science and a Side of Diplomacy

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

New Studies of B.1.1.7

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

PNAS Papers on Acute Kidney Injury, Parental Expression in Horse Placenta, Sea Urchin Microbes

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.

Apr
15
Featured Webinar

Panel Discussion: Data Interpretation in Wastewater Surveillance for SARS-CoV-2

Sponsored by
Combinati

Detection and quantification of SARS-CoV-2 levels in wastewater can be a useful predictor of potential COVID-19 outbreaks. However, the interpretation of the surveillance data can be challenging.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
12
Featured Webinar

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

What's Popular?

In PCR

  1. DiaSorin to Acquire Luminex for $1.8B

  2. Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

    Premium

  3. CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests

    Premium

  4. Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx

    Premium

  5. Ethos Labs, Agena Biosciences Partner on SARS-CoV-2 Variant Identification

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.